Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Types of Radioactivity03:23

Types of Radioactivity

The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Atomic Emission Spectroscopy: Overview01:20

Atomic Emission Spectroscopy: Overview

Atomic emission spectroscopy (AES) is an analytical technique used to determine the elemental composition of a sample by analyzing the light emitted from excited atoms. In AES, atoms in a sample are excited to higher energy levels by thermal energy from high-temperature sources, such as plasma, arcs, or sparks. When these excited atoms return to lower energy states, they emit light at specific wavelengths characteristic of each element. The resulting atomic emission spectrum, which consists of...
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific Dosimetry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Establishing measurement traceability for quantitative SPECT imaging.

EJNMMI physics·2025
Same author

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer.

European thyroid journal·2025
Same author

Rethinking Dosimetry: A European Perspective.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetry.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025
Same author

Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same journal

[<sup>68</sup>Ga]Ga-DOTA-TOC Synthesis by a Cassette Developer System with [<sup>68</sup>Ga]GaCl<sub>3</sub> from Cyclotron using Liquid Target: An Italian Experience.

Current radiopharmaceuticals·2025
Same journal

Evaluating the Effectiveness of Geant4 Software in Measuring the Damage Caused by Ti48 Ion Radiation on Nerve Cells, in Comparison to the Biophysical Model and Empirical Data.

Current radiopharmaceuticals·2025
Same journal

Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006).

Current radiopharmaceuticals·2025
Same journal

Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [<sup>131</sup>I]Sodium Iodide.

Current radiopharmaceuticals·2025
Same journal

RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence.

Current radiopharmaceuticals·2025
Same journal

Nuclear Nanomedicines: Utilization of Radiolabelling Strategies, Drug Formulation, Delivery, and Regulatory Aspects for Disease Management.

Current radiopharmaceuticals·2025
See all related articles

Related Experiment Video

Updated: May 26, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &alpha; and &beta; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Alpha-particle microdosimetry.

Nicolas Chouin1, Manuel Bardies

  • 1Department of Radiation Physics, The Sahlgrenska Academy at the University of Gothenburg, Sweden. nicolas.chouin@gu.se

Current Radiopharmaceuticals
|December 29, 2011
PubMed
Summary
This summary is machine-generated.

Targeted alpha-particle therapy offers precise cancer treatment due to alpha particles' high cytotoxicity and short range. Microdosimetry is crucial for analyzing energy deposition at the cellular level, improving treatment efficacy.

More Related Videos

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities

Published on: February 20, 2021

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Related Experiment Videos

Last Updated: May 26, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &alpha; and &beta; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage (40-300 kV) X-Ray Facilities

Published on: February 20, 2021

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Area of Science:

  • Medical Physics
  • Radiotherapy
  • Nuclear Medicine

Background:

  • Targeted alpha-particle therapy is a promising treatment for hematological cancers and micrometastatic diseases.
  • Alpha particles' high linear energy transfer (LET) and short range offer treatment specificity.
  • Conventional dosimetry is less relevant for alpha-particle therapy due to its unique radiologic features.

Purpose of the Study:

  • To review the role of microdosimetry in targeted alpha-particle therapy.
  • To highlight the importance of stochastic energy deposition analysis at the cellular level.
  • To discuss the challenges and future directions of microdosimetry in this field.

Main Methods:

  • Microdosimetry provides a framework for analyzing stochastic energy deposition.
  • Review of various microdosimetric models and their applications.
  • Analysis of experimental data and modeling of therapeutic scenarios.

Main Results:

  • Microdosimetry accurately describes the high toxicity of alpha particles.
  • Activity distribution at the cellular scale significantly impacts therapy efficacy.
  • Challenges exist in determining in vivo source-target distributions for microdosimetry.

Conclusions:

  • Microdosimetry is essential for understanding targeted alpha-particle therapy.
  • Future advancements depend on high-resolution detectors and pharmacokinetic modeling.
  • Accurate microdosimetric analysis can optimize treatment strategies for minimal residual diseases.